204 related articles for article (PubMed ID: 28842163)
1. Validated spectrophotometric and chromatographic methods for analysis of the recently approved hepatitis C antiviral combination ledipasvir and sofosbuvir.
Baker MM; El-Kafrawy DS; Mahrous MS; Belal TS
Ann Pharm Fr; 2018 Jan; 76(1):16-31. PubMed ID: 28842163
[TBL] [Abstract][Full Text] [Related]
2. Validated spectrophotometric and chromatographic methods for simultaneous determination of ketorolac tromethamine and phenylephrine hydrochloride.
Belal TS; El-Kafrawy DS; Mahrous MS; Abdel-Khalek MM; Abo-Gharam AH
Ann Pharm Fr; 2016 Jul; 74(4):267-82. PubMed ID: 26895689
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous determination of the brand new two-drug combination for the treatment of hepatitis C: Sofosbuvir/ledipasvir using smart spectrophotometric methods manipulating ratio spectra.
Eissa MS
Spectrochim Acta A Mol Biomol Spectrosc; 2017 Aug; 183():362-370. PubMed ID: 28460317
[TBL] [Abstract][Full Text] [Related]
4. Earth-friendly spectrophotometric methods for simultaneous determination of ledipasvir and sofosbuvir: Application to average content and uniformity of dosage unit testing.
El-Shorbagy HI; Elsebaei F; Hammad SF; Elbrashy AM
Spectrochim Acta A Mol Biomol Spectrosc; 2018 Dec; 205():398-409. PubMed ID: 30044997
[TBL] [Abstract][Full Text] [Related]
5. A new innovative spectrophotometric method for the simultaneous determination of sofosbuvir and ledipasvir.
Mansour FR
Spectrochim Acta A Mol Biomol Spectrosc; 2018 Jan; 188():626-632. PubMed ID: 28783604
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a versatile HPLC-DAD method for simultaneous determination of the antiviral drugs daclatasvir, ledipasvir, sofosbuvir and ribavirin in presence of seven potential impurities. Application to assay of dosage forms and dissolution studies.
Baker MM; Hammad SF; Belal TS
Drug Dev Ind Pharm; 2019 Jul; 45(7):1111-1119. PubMed ID: 30929537
[TBL] [Abstract][Full Text] [Related]
7. Spectroflurimetric estimation of the new antiviral agent ledipasvir in presence of sofosbuvir.
Salama FM; Attia KA; Abouserie AA; El-Olemy A; Abolmagd E
Spectrochim Acta A Mol Biomol Spectrosc; 2018 Feb; 190():513-517. PubMed ID: 28968574
[TBL] [Abstract][Full Text] [Related]
8. Comparison between core-shell and totally porous particle stationary phases for fast and green LC determination of five hepatitis-C antiviral drugs.
Ibrahim AE; Hashem H; Elhenawee M; Saleh H
J Sep Sci; 2018 Apr; 41(8):1734-1742. PubMed ID: 29297968
[TBL] [Abstract][Full Text] [Related]
9. Spectrophotometric Methods for Simultaneous Determination of Sofosbuvir and Ledipasvir (HARVONI Tablet): Comparative Study with Two Generic Products.
Abo-Talib NF; El-Ghobashy MR; Tammam MH
J AOAC Int; 2017 Jul; 100(4):976-984. PubMed ID: 28330530
[TBL] [Abstract][Full Text] [Related]
10. Development of a highly sensitive high-performance thin-layer chromatography method for the screening and simultaneous determination of sofosbuvir, daclatasvir, and ledipasvir in their pure forms and their different pharmaceutical formulations.
Saraya RE; Elhenawee M; Saleh H
J Sep Sci; 2018 Sep; 41(18):3553-3560. PubMed ID: 30048040
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous quantification of simeprevir sodium: A hepatitis C protease inhibitor in binary and ternary mixtures with sofosbuvir and/or ledipasvir utilizing direct and H-point standard addition strategies.
Mohamed SH; Issa YM; Salim AI
Spectrochim Acta A Mol Biomol Spectrosc; 2019 Mar; 210():290-297. PubMed ID: 30469132
[TBL] [Abstract][Full Text] [Related]
12. Chemometrically Assisted Development of Ultra-High-Performance Liquid Chromatography Method for the Simultaneous Quantification of Sofosbuvir, Daclatasvir and Ledipasvir in Pharmaceutical Dosage Forms.
Labidi A; El Atrache LL
J Chromatogr Sci; 2020 Jan; 57(10):910-919. PubMed ID: 31644804
[TBL] [Abstract][Full Text] [Related]
13. Investigation of anti-Hepatitis C virus, sofosbuvir and daclatasvir, in pure form, human plasma and human urine using micellar monolithic HPLC-UV method and application to pharmacokinetic study.
Zidan DW; Hassan WS; Elmasry MS; Shalaby AA
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jun; 1086():73-81. PubMed ID: 29660665
[TBL] [Abstract][Full Text] [Related]
14. Chemometric simultaneous determination of Sofosbuvir and Ledipasvir in pharmaceutical dosage form.
Khalili M; Sohrabi MR; Mirzabeygi V; Torabi Ziaratgahi N
Spectrochim Acta A Mol Biomol Spectrosc; 2018 Apr; 194():141-151. PubMed ID: 29331815
[TBL] [Abstract][Full Text] [Related]
15. Validated stability-indicating HPLC-DAD method for determination of the recently approved hepatitis C antiviral agent daclatasvir.
Baker MM; El-Kafrawy DS; Mahrous MS; Belal TS
Ann Pharm Fr; 2017 May; 75(3):176-184. PubMed ID: 28187879
[TBL] [Abstract][Full Text] [Related]
16. Efficient HPTLC-dual wavelength spectrodensitometric method for simultaneous determination of sofosbuvir and daclatasvir: Biological and pharmaceutical analysis.
Abo-Zeid MN; El-Gizawy SM; Atia NN; El-Shaboury SR
J Pharm Biomed Anal; 2018 Jul; 156():358-365. PubMed ID: 29753282
[TBL] [Abstract][Full Text] [Related]
17. Validated Reversed-Phase Liquid Chromatographic Method with Gradient Elution for Simultaneous Determination of the Antiviral Agents: Sofosbuvir, Ledipasvir, Daclatasvir, and Simeprevir in Their Dosage Forms.
Ezzeldin E; Abo-Talib NF; Tammam MH; Asiri YA; Amr AEE; Almehizia AA
Molecules; 2020 Oct; 25(20):. PubMed ID: 33050433
[TBL] [Abstract][Full Text] [Related]
18. Spectrophotometric assessment of the brand new antiviral combination: Sofosbuvir and velpatasvir in their pure forms and pharmaceutical formulation.
Rezk MR; Monir HH; Marzouk HM
Spectrochim Acta A Mol Biomol Spectrosc; 2019 Apr; 213():159-166. PubMed ID: 30685554
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of spectrophotometric and HPTLC methods for simultaneous determination of rosiglitazone maleate and metformin hydrochloride in the presence of interfering matrix excipients.
Mahgoub H; Youssef RM; Korany MA; Khamis EF; Kamal MF
Drug Dev Ind Pharm; 2014 Sep; 40(9):1190-8. PubMed ID: 23829222
[TBL] [Abstract][Full Text] [Related]
20. Innovative derivative/zero ratio spectrophotometric method for simultaneous determination of sofosbuvir and ledipasvir: Application to average content and uniformity of dosage units.
El-Shorbagy HI; Belal F
Spectrochim Acta A Mol Biomol Spectrosc; 2022 Feb; 267(Pt 2):120623. PubMed ID: 34810100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
